Opaleye Management Inc. Tg Therapeutics, Inc. Transaction History

Opaleye Management Inc.

$548 Million
Q3 2024

A detailed history of Opaleye Management Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 2,280,000 shares of TGTX stock, worth $78.4 Million. This represents 9.74% of its overall portfolio holdings.

Number of Shares

2,280,000

Previous 2,280,000 -0.0%

Holding current value

$78.4 Million

Previous $40.6 Million 31.48%

% of portfolio

9.74%

Previous 10.39%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $846,300 - $1.38 Million	65,000 Added 2.93%	2,280,000 $34.7 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $2.17 Million - $6.11 Million	325,000 Added 17.2%	2,215,000 $37.8 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $15.8 Million - $50.1 Million	1,890,000 New	1,890,000 $15.8 Million
Q1 2021 May 18, 2021	SELL	$41.61 - $54.3 $16.1 Million - $21 Million	-387,500 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$25.27 - $54.9 $63,175 - $137,250	-2,500 Reduced 0.64%	387,500 $20.2 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $1.23 Million - $1.81 Million	-66,600 Reduced 14.59%	390,000 $10.4 Million
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $323,960 - $794,976	-36,400 Reduced 7.38%	456,600 $8.9 Million
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $618,688 - $1.39 Million	-86,651 Reduced 14.95%	493,000 $4.85 Million
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $167,529 - $367,908	-32,849 Reduced 5.36%	579,651 $6.43 Million
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $2.89 Million - $4.83 Million	-537,500 Reduced 46.74%	612,500 $3.44 Million
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $1.35 Million - $1.87 Million	-216,062 Reduced 15.82%	1,150,000 $9.95 Million
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $3.28 Million - $6.56 Million	816,062 Added 148.37%	1,366,062 $11 Million
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $688,000 - $1.15 Million	200,000 Added 57.14%	550,000 $2.26 Million
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $1.42 Million - $3.85 Million	-275,000 Reduced 44.0%	350,000 $1.96 Million
Q2 2018 Aug 14, 2018	BUY	$12.5 - $15.0 $4.39 Million - $5.26 Million	350,800 Added 127.94%	625,000 $8.22 Million
Q1 2018 May 14, 2018	BUY	$8.7 - $16.8 $2.39 Million - $4.61 Million	274,200 New	274,200 $3.89 Million

Others Institutions Holding TGTX

# of Institutions

339

Shares Held

88.5M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Tg Therapeutics, Inc. Transaction History